PhosphoRus, Proton Imaging and Amyloid BuRdEn (PREPARE) ON AMYLOID BURDEN AND COGNITION

CompletedOBSERVATIONAL
Enrollment

37

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

February 24, 2023

Study Completion Date

February 24, 2023

Conditions
Alzheimer Disease
Interventions
DIAGNOSTIC_TEST

Measure of OxPhos upregulation

OxPhos upregulation \[i.e., lower phosphocreatine (PCr)-to-ATP ratio levels\] in the PET AG mask. PIB+ NL subjects will show OxPhos downregulation (i.e. increased PCr/ATP ratio that indicate the presence of metabolically inert PCr that cannot be used as ATP) when compared to PIB- NL subjects in the PETAG mask

DIAGNOSTIC_TEST

lactate (measured with 1H-MRSI)

PIB+ NL subjects will show increased levels of lactate (measured with 1H-MRSI) when compared to PIB- NL subjects in the PETAG mask.

Trial Locations (1)

10016

New York University School of Medicine, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT03999879 - PhosphoRus, Proton Imaging and Amyloid BuRdEn (PREPARE) ON AMYLOID BURDEN AND COGNITION | Biotech Hunter | Biotech Hunter